Clinical Trial Update: Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis

View source ↗

Summary

A completed clinical trial evaluating Diphereline 3.75 mg for internal genital endometriosis sponsored by Ipsen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Diphereline 3.75 mg (triptorelin)

Snippet

Sponsor: Ipsen | Conditions: Internal Endometriosis | Status: COMPLETED